Table of Contents
Description
Johnson & Johnson is currently seeking a Director, Strategic Marketing Haematology– Bispecifics Commercial Lead.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
This role will:
- Shape the Strategy Tecvelyi and Talvey for the Haematology portfolio, with a specific focus on Health Decision Makers, KOLs, and Health Care Providers to support the use of J&J IM products in the treatment of Multiple Myeloma within the Asia Pacific Region.
- Lead, support and develop accelerated growth strategies by driving stronger strategy alignment, deeper market insights, closer collaboration at region & global levels as well as strong engagement across Commercial, Market Access, Medical Affairs and R&D.
- Ensure development of future assets to be fit for purpose for Asia Pacific region by influencing GCSO and R&D colleagues ensuring earliest possible timing for commercialisation
- Be responsible for the execution of both long and short term strategic business plans
- Be an effective and impactful conduit between Global and Local teams.
- Responsible for coaching & developing commercial capabilities of individuals who are technically able and who consistently execute the strategies of the business plan to deliver positive business results.
- Identify and coordinate resources, monitor operating expenses, and maintain key relationships essential to achieving growth and profitability targets, regardless of market conditions.
- Elevate our commercial strategies to high performance, outcomes-focused, where diversity and inclusion are valued, and where the team’s skills, knowledge, and abilities continually evolve to meet future needs.
- Consistently strive to achieve performance excellence.
- Develop and apply next generation analytics, knowledge of the marketplace, clinical, and customer expertise.
Qualifications
- A minimum of a Bachelor’s Degree is required
- A Master’s Degree in a related field or an MBA is preferred
- A minimum of eight (8) years of professional Sales and Sales Management or Marketing and /or Marketing Management experience within the pharmaceutical, biotech, medical device or healthcare industry is required
- A minimum of two years in Marketing and/or Marketing Management or a Commercial Excellence / Analytics function is required
- A minimum of three (3) years of experience managing and leading a cross functional / cross geographic team is strongly preferred.
- Experience in haematology and/or Oncology therapeutic area preferred.
- Pharmaceutical, Companion Diagnostics and Healthcare industry expertise with a deep understanding of the key stakeholders within the stated region is strongly preferred.
- This position will be located in Singapore and require 50% travel. Flexibility of location may be considered where appropriate.
Dr. Qin, can you elaborate on how advancements in research and development are influencing the landscape of treatment options available for patients with haematological disorders?
Welcome to World Today News. Today, we are pleased to have with us Mr. David Kim, Director of Global Talent Acquisition at Johnson & Johnson, and Dr. Jane Qin, a renowned Oncology specialist from Singapore General Hospital. Thank you both for joining us today.
Mr. Kim, could you tell us more about the current job opening at Johnson & Johnson for a Director of Strategic Marketing Haematology– Bispecifics Commercial Lead in the Asia Pacific Region? What qualifications and experience are you looking for in this role?
Mr. David Kim: Of course! We are seeking an individual who has a minimum of a Bachelor’s Degree and a Master’s Degree in a related field or MBA. Additionally, we require at least eight years of professional Sales and Sales Management or Marketing and /or Marketing Management experience within the pharmaceutical, biotech, medical device or healthcare industry, with two years in Marketing and/or Marketing Management or a Commercial Excellence / Analytics function. Candidates must also have three years of experience managing and leading a cross-functional / cross-geographic team and preferably expertise in haematology and/or Oncology therapeutic area. The position will be located in Singapore and require 50% travel. Individuals who possess flexibility of location within the region will also be considered.
Moving on to Dr. Qin, as an Oncology specialist, how crucial is it for pharmaceutical companies like Johnson & Johnson to invest in research and development for treatments in Haematology and Multiple Myeloma specifically?
Dr. Jane Qin: Investing in research and development for treatments in Haematology and Multiple Myeloma is crucial for several reasons. First, these diseases often require specialized treatments and therapies that are constantly evolving. Second, there is still a lot of work to be done in terms of developing more effective and personalized treatments that can improve patient outcomes and quality of life. there is a growing demand for treatments in this field due to an aging population and increased health awareness, which means that pharmaceutical companies that invest in R&D can potentially reap significant rewards in the future.
David,
